Reference
Roche. Roche halts investigation of aleglitazar following regular safety review of phase III trial. Media Release : 10 Jul 2013. Available from: URL: http://www.roche.com
Rights and permissions
About this article
Cite this article
Roche halts antidiabetic's development in phase III. Reactions Weekly 1461, 4 (2013). https://doi.org/10.1007/s40278-013-4525-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-4525-4